MoneyWorks4Me

Jubilant Pharmova informs about investment updates

01 Jun 2021 Evaluate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that it enclosed a communication pertaining to investment of $92 million by Jubilant Pharma, a wholly-owned subsidiary of the Company for expansion of sterile injectable manufacturing capacity at the Spokane site in Washington, US.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..